Welcome to our dedicated page for Carecloud SEC filings (Ticker: CCLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning a 300-page healthcare IT filing for clues about HIPAA risks or subscription churn is time-consuming. CareCloud’s disclosures weave SaaS accounting rules, cybersecurity safeguards, and healthcare regulations into dense language that leaves many investors asking, “How do I even start?”.
Stock Titan turns that problem on its head. Our AI-powered summaries break down every CareCloud annual report 10-K simplified, flagging where revenue cycle management fees outpaced EHR subscriptions and highlighting new telehealth cost drivers. Need the latest CareCloud quarterly earnings report 10-Q filing? It arrives on the platform within seconds of EDGAR release, complete with plain-English trend analysis. Curious about executive activity? Follow CareCloud insider trading Form 4 transactions and CareCloud Form 4 insider transactions real-time to spot buying or selling before it hits the news. You can also explore CareCloud 8-K material events explained, so surprise contract wins or data-breach updates never slip by.
Whether you’re monitoring CareCloud proxy statement executive compensation to evaluate incentive alignment or seeking CareCloud earnings report filing analysis to compare margins across segments, our coverage delivers. The dashboard links every form—10-K, 10-Q, 8-K, S-3, DEF 14A—with AI context layers so understanding CareCloud SEC documents with AI becomes second nature. Track CareCloud executive stock transactions Form 4, download exhibits, and set alerts for changes that matter. Complex filings, clarified—so you can focus on decisions, not deciphering.
CareCloud, Inc. filed its Q3 2025 report, showing higher revenue and profitability. Net revenue was
For the nine months, revenue reached
The company closed two acquisitions: Medsphere Systems for
CareCloud, Inc. furnished materials related to its results of operations and financial condition. The company provided a press release and an accompanying slide presentation, delivered under Item 2.02 and Item 7.01, respectively. The materials are furnished and not deemed filed under the Exchange Act.
Exhibits include 99.1 (press release dated November 6, 2025), 99.2 (slide presentation dated November 6, 2025), and 104 (Cover Page Inline XBRL). CareCloud’s securities trade on the Nasdaq Global Market under CCLD (common stock) and CCLDO (8.75% Series B Preferred). The report was signed by Interim CFO and Corporate Controller Norman Roth.
CareCloud, Inc. (CCLD) filed an Amendment No. 1 to Form 8-K to complete its earlier acquisition disclosure for Medsphere Systems Corporation. The amendment adds the required financial statements of the acquired business and unaudited pro forma combined information under Item 9.01(a) and (b).
Exhibits include Medsphere’s audited financials as of December 31, 2024 and 2023, unaudited interim financials as of June 30, 2025, and unaudited pro forma condensed combined information covering the acquisitions of Medsphere, RevNu, and Mesa. Other disclosures from the original report remain unchanged.
Mahmud Ul Haq, identified as Executive Chairman, Director and a 10% owner of CareCloud, Inc. (CCLD), reported a sale of 11,960 shares of Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) on 09/29/2025. The reported weighted-average sale price was $21.08, with transaction prices ranging from $20.91 to $21.23, and the filing states the sale reduced the reporting person’s beneficial ownership of this class to 0 shares. The Form 4 was executed by Norman Roth as attorney-in-fact and discloses the reporting person filed individually.
Form 144 notice for CCLD Preferred Series B: The filing reports a proposed sale of 11,960 shares of CCLDO Preferred Series B with an aggregate market value of $252,000 on an approximate sale date of 09/29/2025 on NASDAQ. The broker listed is Chapin Davis Investments (address provided). The securities were acquired from CareCloud, Inc. as compensation: 5,480 shares on 02/19/2022 and 6,480 shares on 12/16/2024, matching the total to be sold. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.